Digital Maternal Support Tool Implementation
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT07295015
- Status
- Recruiting
Conditions
- Postpartum
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Not accepted
Interventions
- Smartphone application — OTHERThe smartphone app is designed to provide postpartum education, screening and tracking, and positive parenting support for newly postpartum English-language speakers in Pennsylvania.
Study Details
The goal of this trial is to learn if a smartphone app designed to provide postpartum support is acceptable to new mothers in Pennsylvania. The main questions it aims to answer are: * How easy is the app is to use? * Does the app meet the needs of new parents? * Is using the app associated with better understanding of critical postpartum symptoms? * Is using the app associated with endorsement of positive parenting statements? Participants will: * Use a postpartum support app on their smartphones for 8 weeks * Answer survey questions about their experience
Key Dates
- Start date
- Dec 1, 2025
- Status verified
- Dec 2025
- Primary completion
- Sep 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Postpartum support appAll study participants will be given access to a postpartum support app. They will be asked to use this app for 8 weeks. Periodic surveys will be administered at 10 days, 4 weeks, and 8 weeks post enrollment. Baseline measurements will be collected at enrollment.
Primary Outcome Measure
Acceptability of App [ Time Frame: Day 10, Week 4, and Week 8 of study participation ]
Central Contacts
- Tamar Krishnamurti, PhD412-383-5556
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UPMC Magee-Womens Hospital | Pittsburgh | Pennsylvania | 15213 |
Find similar trials in Pittsburgh, PA
By research site
Related Studies
- Excretion of Rivaroxaban in Human Breast MilkPHASE1 · Recruiting · Thomas Jefferson University · Philadelphia, Pennsylvania
- Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal WellnessNot Yet Recruiting · Oregon Health and Science University · Santa Barbara, California
- Mobile Application-based Exercise Intervention for Pregnant WomenRecruiting · Western Kentucky University · Bowling Green, Kentucky
- Drug Excretion in Breast MilkPHASE4 · Recruiting · University of Washington · Seattle, Washington